What are the treatment options for a patient with hyperammonemia (elevated ammonia level) of 78?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ammonia Level 78 µmol/L (133 µg/dL)

An ammonia level of 78 µmol/L represents mild hyperammonemia that requires immediate intervention with nitrogen-scavenging agents and nutritional management, but does not yet meet the threshold for dialysis unless accompanied by severe neurological symptoms. 1, 2

Clinical Context and Severity Assessment

This ammonia level is:

  • Elevated above normal for term infants, children, and adolescents (normal <50 µmol/L or 85 µg/dL) 1
  • Below the threshold for urgent dialysis (300-400 µmol/L) 1, 2
  • Requires immediate treatment to prevent progression to severe hyperammonemia and irreversible neurological damage 2, 3

Assess neurological status immediately using West Haven criteria or Glasgow Coma Scale to determine encephalopathy severity, as this guides treatment intensity more than the absolute ammonia number 3

Immediate Medical Management

Nutritional Intervention (First-Line)

Stop all oral protein intake immediately to reduce nitrogen load and prevent further ammonia production 1, 4, 2

Provide adequate calories as intravenous glucose and lipids:

  • Maintain glucose infusion rate of 8-10 mg/kg/min 1, 4, 2
  • Administer lipids starting at 0.5 g/kg daily, up to 3 g/kg daily 1, 4, 2
  • Target total caloric intake ≥100 kcal/kg daily to prevent protein catabolism, which would worsen hyperammonemia 1, 4

Gradually reintroduce protein within 48 hours (by 0.25 g/kg daily, up to 1.5 g/kg daily) once ammonia levels begin normalizing—prolonged protein restriction beyond 48 hours causes catabolism that paradoxically increases ammonia production 1, 4, 2

Pharmacological Therapy

Administer nitrogen-scavenging agents immediately at weight-based dosing 1, 2:

Intravenous sodium benzoate:

  • Body weight <20 kg: 250 mg/kg 1, 2
  • Body weight >20 kg: 5.5 g/m² 1, 2
  • Given over 90 minutes as bolus, then as continuous maintenance over 24 hours 1
  • Maximum dose 12 g daily (high-dose benzoate can be toxic and lethal within 1 hour) 1

Intravenous sodium phenylacetate (same dosing as benzoate):

  • Body weight <20 kg: 250 mg/kg 1, 2
  • Body weight >20 kg: 5.5 g/m² 1, 2
  • Given over 90 minutes as bolus, then as continuous maintenance over 24 hours 1

Add L-arginine hydrochloride if urea cycle disorder suspected 1, 2:

  • For OTC and CPS deficiencies: 200 mg/kg (if <20 kg) or 4 g/m² (if >20 kg) 1
  • For ASS and ASL deficiencies: 600 mg/kg (if <20 kg) or 12 g/m² (if >20 kg) 1

Consider L-carnitine if organic acidemia suspected: 50 mg/kg loading dose over 90 minutes, then 100-300 mg/kg daily 1, 2

Lactulose for Hepatic Encephalopathy

If liver disease is the underlying cause, administer lactulose 15-30 mL orally or via nasogastric tube every 1-2 hours until bowel movement, then adjust to achieve 2-3 soft stools daily 5

  • Lactulose reduces blood ammonia levels by 25-50% and improves mental state in about 75% of patients with hepatic encephalopathy 5
  • Important caveat: Research shows ammonia levels do not correlate with lactulose dosing in clinical practice, and normal ammonia in a cirrhotic patient with neurological symptoms should prompt reconsideration of hepatic encephalopathy diagnosis 6, 7

Monitoring Protocol

Check plasma ammonia levels every 3-4 hours until normalized 4, 2, 3

Critical sampling technique: Ammonia samples must be collected from free-flowing venous or arterial blood, transported on ice, and processed within 15 minutes to avoid false elevations 4, 2, 3

Assess neurological status continuously for signs of encephalopathy progression (lethargy, confusion, hyperventilation, seizures, coma) 1, 2, 3

Monitor electrolytes, renal function, and acid-base status regularly 4, 3

When to Escalate to Dialysis

Hemodialysis or continuous kidney replacement therapy (CKRT) is NOT indicated at this ammonia level unless specific criteria are met 1, 2:

Indications for urgent dialysis:

  • Ammonia levels >300-400 μmol/L despite medical therapy 1, 4, 2
  • Rapidly deteriorating neurological status, coma, or cerebral edema 1, 4
  • Rapid rise in ammonia levels >300 μmol/L within a few hours that cannot be controlled with medical measures 1

Hemodialysis is most effective for rapid ammonia reduction (50% reduction within 1-2 hours, 95-96% filtration fraction) 4, 2

For hemodynamically unstable patients, CKRT (specifically high-dose CVVHD) is preferred over intermittent hemodialysis 1, 4, 2

Diagnostic Workup

Identify the underlying cause while treating 3:

  • Obtain plasma amino acid profile, urine organic acids, plasma acylcarnitine profile 3
  • Check liver function tests, lactate, pyruvate 3
  • Review medications (especially valproic acid) 1, 8
  • Assess for infections, constipation, dehydration, alkalosis 3
  • Consider genetic testing for urea cycle disorders if etiology unclear 3

Common Pitfalls to Avoid

Delayed treatment leads to irreversible neurological damage—hyperammonemia causes cerebral edema, astrocyte swelling, and neuronal injury through glutamine accumulation and inflammatory cytokine release 1, 2

Do not prolong protein restriction beyond 48 hours—this causes protein catabolism that paradoxically worsens hyperammonemia 1, 4, 2

Improper ammonia sampling causes false elevations—hemolysis, delayed processing, or prolonged tourniquet use can falsely elevate results 4, 2, 3

Nitrogen scavengers are dialyzed during CKRT but remain effective when used concurrently 4, 2

In cirrhotic patients with normal ammonia and neurological symptoms, reconsider the diagnosis of hepatic encephalopathy and investigate alternative causes 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Workup for Severe Acute Hyperammonemia of Uncertain Origin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated Ammonia Levels in Bowel Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Why and when to measure ammonemia in cirrhosis?

Clinics and research in hepatology and gastroenterology, 2018

Research

Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Pediatric nephrology (Berlin, Germany), 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.